Department of Orthodontics and Pediatric Dentistry, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
Orthod Craniofac Res. 2020 Feb;23(1):35-43. doi: 10.1111/ocr.12350. Epub 2019 Oct 25.
The goal of this study was to investigate potential negative sequelae of orthodontic force application ±delivery of an osteoclast inhibitor, recombinant osteoprotegerin protein (OPG-Fc), on periodontal tissues.
Sprague Dawley rats from a commercial supplier were investigated in a laboratory setting.
Rats were randomly divided into four groups (n = 7 each): one group with no orthodontic appliances and injected once prior to the experimental period with empty polymer microspheres, one group with orthodontic appliances and injected once with empty microspheres, one group with orthodontic appliances and injected once with polymer microspheres containing 1 mg/kg of OPG-Fc, and one group with orthodontic appliances and injected with non-encapsulated 5 mg/kg of OPG-Fc every 3 days during the experimental period. The animals were euthanized after 28 days of tooth movement for histomorphometric analyses.
Root resorption, PDL area and widths were similar in animals without appliances and animals with appliances plus high-dose OPG-Fc. PDL blood vessels were compressed and decreased in number in all animals that received orthodontic appliances, regardless of OPG-Fc. Hyalinization was significantly increased only in animals with orthodontic appliances plus multiple injections of 5 mg/kg non-encapsulated OPG-Fc when compared to animals without appliances.
Results of this study indicate that while pharmacological modulation of tooth movement through osteoclast inhibition is feasible when delivered in a locally controlled low-dose manner, high-dose levels that completely prevent tooth movement through bone may decrease local blood flow and increase the incidence of hyalinization.
本研究旨在探讨正畸力应用的潜在负面后果——给予破骨细胞抑制剂、重组骨保护素蛋白(OPG-Fc)对牙周组织的影响。
在实验室环境中,研究了来自商业供应商的 Sprague Dawley 大鼠。
大鼠随机分为四组(每组 n=7):一组无正畸矫治器,在实验前单次注射空聚合物微球;一组有正畸矫治器,单次注射空微球;一组有正畸矫治器,单次注射含 1mg/kg OPG-Fc 的聚合物微球;一组有正畸矫治器,在实验期间每 3 天注射一次非包裹的 5mg/kg OPG-Fc。在牙齿移动 28 天后,处死动物进行组织形态计量学分析。
无矫治器组和矫治器加高剂量 OPG-Fc 组的牙根吸收、牙周膜面积和宽度相似。所有接受正畸矫治器的动物的牙周膜血管均受压并减少,无论是否给予 OPG-Fc。仅在接受正畸矫治器加多次注射 5mg/kg 非包裹 OPG-Fc 的动物中,玻璃样变显著增加,与无矫治器的动物相比。
本研究结果表明,虽然通过破骨细胞抑制来调节牙齿移动的药理学方法在局部控制的低剂量下是可行的,但完全通过骨来阻止牙齿移动的高剂量可能会降低局部血流并增加玻璃样变的发生率。